Systematic Reviews of Treatments for Liver Diseases

Follow the links below to find summaries of systematic reviews of the evidence for treatments for liver diseases.

Created October 2007

Printer friendly page

39 Resources Found
Results 1 to 20 displayed.
1    2   
Title:   Systematic Reviews of Treatments for Cirrhosis of the Liver
Publisher:   HealthInsite Topic Page
Description:   Links to systematic reviews of the evidence for the effectiveness of treatments for cirrhosis of the liver.
Date:   Jan 2008
Title:   Hepatic artery adjuvant chemotherapy for patients having resection or ablation of colorectal cancer metastatic to the liver
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Patients who die of colorectal cancer usually die from, or at least with, liver metastases. On the other hand, isolated liver metastases can, on occasion, be resected with a chance of cure, if metastatic disease is not present elsewhere. After liver res...
Date:   Jul 2006
Title:   Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   No sufficient evidence to prove with certainty that human recombinant activated factor VII reduces or not the risk of death in patients with liver disease suffering from upper gastrointestinal bleeding We could not test in a meta-analysis whether human ...
Date:   Aug 2006
Title:   Antifibrinolytic amino acids for acquired coagulation disorders in patients with liver disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Randomised clinical trials with antifibrinolytic amino acids for upper gastrointestinal bleeding in patients with liver disease plus acquired coagulation disorders could not be found....
Date:   Aug 2006
Title:   Terlipressin for acute esophageal variceal hemorrhage
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Esophageal varices are abnormal dilatations of veins in the lower part of the swallowing tube (esophagus) that may develop in patients with chronic liver damage (cirrhosis). Bleeding from these varices is a life threatening complication with mortality b...
Date:   Oct 2002
Title:   Bicyclol for chronic hepatitis B
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Evidence on beneficial or harmful effects of bicyclol for chronic hepatitis C is not found. Bicyclol is a novel synthetic 'anti-hepatitis' drug, used primarily in China for patients with chronic hepatitis B. No well-designed randomised clinical trials wer...
Date:   Aug 2006
Title:   Dopaminergic agonists for hepatic encephalopathy
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   No evidence to support or refute that dopaminergic agonists have an effect on hepatic encephalopathy ...
Date:   Aug 2004
Title:   Colchicine for primary biliary cirrhosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   No convincing evidence either to support or refute the use of colchicine for patients with primary biliary cirrhosis ...
Date:   Feb 2004
Title:   Antibiotic prophylaxis for cirrhotic patients with gastrointestinal bleeding
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Patients with liver cirrhosis can bleed from the gastrointestinal system. When these patients are hospitalised, they are prone to bacterial infections. Because bacterial infections increase the risk of death among these patients, antibiotic prophylaxis ...
Date:   Jan 2002
Title:   TIPS versus paracentesis for cirrhotic patients with refractory ascites
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Patients with refractory ascites may temporarily benefit from transjugular intrahepatic portosystemic stent-shunts ...
Date:   Aug 2006
Title:   Propylthiouracil for alcoholic liver disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Evidence supporting or refuting propylthiouracil for alcoholic liver disease was not found ...
Date:   Aug 2005
Title:   Benzodiazepine receptor antagonists for hepatic encephalopathy
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Hepatic encephalopathy refers to changes in mental state, ranging from minor signs of altered brain function to deep coma occurring in patients with liver failure. Hepatic encephalopathy may be caused by an activation of a receptor-complex in the brain....
Date:   Feb 2004
Title:   Cyclosporin A for primary biliary cirrhosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Cyclosporin A was without significant effects on mortality, liver transplantation, or progression of primary biliary cirrhosis, and patients given cyclosporin A experienced more adverse eventsPrimary biliary cirrhosis (PBC) is a chronic disease of the l...
Date:   May 2007
Title:   Azathioprine for primary biliary cirrhosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   There is no evidence to support azathioprine for patients with primary biliary cirrhosisPrimary biliary cirrhosis (PBC) is a chronic disease of the liver that is characterised by destruction of bile ducts. Estimates of annual incidence range from 2 to 2...
Date:   May 2007
Title:   Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   No evidence to support or refute the effect of bile acids in patients with non-alcoholic fatty liver disease and/or steatohepatitis ...
Date:   Sep 2006
Title:   Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Portosystemic shunts compared with sclerotherapy/banding lowers variceal rebleeding, but increases hepatic encephalopathyA third of deaths from cirrhosis are due to variceal bleeding. Randomised clinical trials have compared three types of portosystemic...
Date:   Aug 2006
Title:   S-adenosyl-L-methionine for alcoholic liver diseases
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   No evidence to support or refu t e S-adenosyl-L-methionine for alcoholic liver diseases ...
Date:   Feb 2006
Title:   Anabolic-androgenic steroids for alcoholic liver disease
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   No evidence to support anabolic-androgenic steroids for alcoholic liver disease ...
Date:   Aug 2006
Title:   Antacids for preventing oesophagogastric variceal bleeding and rebleeding in cirrhotic patients
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Randomised trials with antacids for preventing oesophagogastric variceal bleeding and bleeding in cirrhotic patients could not be found. Valid evidence for or against the use of antacids for preventing oesophagogastric variceal bleeding and bleeding in ...
Date:   Feb 2008
Title:   Branched-chain amino acids for hepatic encephalopathy
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Hepatic encephalopathy occurs in patients with chronic liver disease or fulminant liver failure and is associated with changes in mental state, ranging from minor signs of altered brain function to deep coma. Treatment with branched-chain amino acids ha...
Date:   Sep 2002
Results 1 to 20 displayed.
1    2   

  • Other Related Topics: